Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Priya R. Chandrasekaran"'
Autor:
Priya R. Chandrasekaran, Hiok Hong Chan, Tien-En Tan, Farah N.I. Ibrahim, Jinzhi Zhao, Kelvin Y.C. Teo
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 34, Iss , Pp 102016- (2024)
Purpose: To report a case of secondary Multiple Evanescent White Dot Syndrome in a patient with preexisting wet age-related macular degeneration. Observation: A 75-year-old male on treat and extend regimen for wet age-related macular degeneration (AM
Externí odkaz:
https://doaj.org/article/4b5d157d52a046308c3fd79b81c370e1
Autor:
Farah N. I. Ibrahim, Kelvin Y. C. Teo, Tien-En Tan, Hiok Hong Chan, Priya R. Chandrasekaran, Shu-Yen Lee, Anna C. S. Tan, Ranjana Mathur, Choi Mun Chan, Shaun S. Sim, Gavin Siew Wei Tan, Ian Y. S. Yeo, Chui Ming Gemmy Cheung
Publikováno v:
Frontiers in Ophthalmology, Vol 3 (2024)
PurposeTo describe the early experiences of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV) whose treatment was switched to faricimab from other anti-vascular endothelial growth factor (VE
Externí odkaz:
https://doaj.org/article/57f2acf667dc4a1a9b5ee5d36078a8a6
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Retinal vein occlusions (RVOs) are the second most common retinal vascular disease after diabetic retinopathy, and are a significant cause of visual impairment, especially in the elderly population. RVOs result in visual loss due to macular ischemia,
Externí odkaz:
https://doaj.org/article/e8b46a05d57b44698e7caf7fa6b42178
Publikováno v:
Therapeutic Advances in Ophthalmology, Vol 14 (2022)
Ranibizumab has proven its efficacy in various retinal diseases and particularly in neovascular age-related macular degeneration (nAMD). The number of injections and the frequent follow-up visits has been burdensome to patients particularly during th
Externí odkaz:
https://doaj.org/article/d51f768c6b7645be9bb825a3387419d5
Publikováno v:
Therapeutic Advances in Ophthalmology, Vol 13 (2021)
KSI-301 is a new intravitreal anti-vascular endothelial growth factor (VEGF) antibody biopolymer conjugate under investigation for the treatment of age-related macular degeneration (AMD), diabetic macular oedema (DME) and retinal vein occlusion (RVO)
Externí odkaz:
https://doaj.org/article/a3c508e64cf34487bb80d6f0de1100e5
Publikováno v:
Clinical Ophthalmology. 17:197-207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49d233140d1348c8d645ea7196d0f735
https://doi.org/10.2147/opth.s388327
https://doi.org/10.2147/opth.s388327
Autor:
Priya R. Chandrasekaran
Publikováno v:
Feminist Formations. 34:215-219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2db6216fd4e9bbb4214bdb06d65a82bc
https://doi.org/10.1353/ff.2022.0030
https://doi.org/10.1353/ff.2022.0030
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology
Purpose To review the role of curcumin in retinal diseases, COVID era, modification of the molecule to improve bioavailability and its future scope. Methods PubMed and MEDLINE searches were pertaining to curcumin, properties of curcumin, curcumin in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2eace8e3d4360878469176916d2a598
https://doi.org/10.1007/s00417-021-05542-0
https://doi.org/10.1007/s00417-021-05542-0
Autor:
Kai Xiong Cheong, Charles Jit Teng Ong, Priya R Chandrasekaran, Jinzhi Zhao, Kelvin Yi Chong Teo, Ranjana Mathur
Publikováno v:
Diagnostics. 13:1752
This review provides an overview of conventional and novel retinal imaging modalities for hydroxychloroquine (HCQ) retinopathy. HCQ retinopathy is a form of toxic retinopathy resulting from HCQ use for a variety of autoimmune diseases, such as rheuma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a74aab4c443798486d71bf59bfae8db
https://doi.org/10.3390/diagnostics13101752
https://doi.org/10.3390/diagnostics13101752
Publikováno v:
Diagnostics. 13:1680
Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration (nAMD) that is characterized by a branching neovascular network and polypoidal lesions. It is important to differentiate PCV from typical nAMD as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1fc23912ce29e28b38d757979e82689
https://doi.org/10.3390/diagnostics13101680
https://doi.org/10.3390/diagnostics13101680